TVGN
NASDAQ · Biotechnology
Tevogen Bio Holdings Inc
$6.98
+0.26 (+3.87%)
Open$6.59
Previous Close$6.72
Day High$7.01
Day Low$6.59
52W High$40.45
52W Low$3.64
Volume—
Avg Volume6.2K
Market Cap45.45M
P/E Ratio—
EPS$-6.80
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+200.3% upside
Current
$6.98
$6.98
Target
$20.96
$20.96
$15.05
$20.96 avg
$24.54
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 26.00M | 22.93M | 28.87M |
| Net Income | -3,802,417 | -3,978,629 | -3,915,216 |
| Profit Margin | -14.6% | -17.4% | -13.6% |
| EBITDA | -5,256,206 | -4,739,765 | -5,087,055 |
| Free Cash Flow | -3,224,852 | -2,115,724 | -2,331,954 |
| Rev Growth | +20.6% | +0.2% | +12.7% |
| Debt/Equity | 0.27 | 0.28 | 0.30 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $262.82 | +1.11% | 72.8 | 459.33B |
| AMGN | Amgen Inc | $403.04 | -1.04% | 25.1 | 219.33B |
| GILD | Gilead Sciences Inc | $144.74 | -1.87% | — | 179.15B |
| VRTX | Vertex Pharmaceuticals Inc | $504.73 | -0.40% | 30.1 | 132.51B |
| REGN | Regeneron Pharmaceuticals | $735.20 | +0.05% | 17.4 | 75.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.72 | -4.96% | 36.9 | 29.82B |